Induction therapy (IT) with paclitaxel (P) and CBDCA (C) followed by hyperfractionated radiotherapy (HFR) + weekly concurrent chemotherapy (WT) and subsequent manteinance therapy in unresectable NSCLC (Stage IIIA N2 bulky, Stage IIIB)
Lung Cancer（2000）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要